Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Santa Clara, California–(Newsfile Corp. – August 26, 2025) – Meshy.ai, an AI-powered 3D content generation platform, has announced the launch of Meshy 5, a major upgrade in AI-driven 3D modeling technology. Building on the success of Meshy 4, this release delivers significant improvements in texture generation, structural stability, and creative flexibility, establishing a new standard for production-ready 3D workflows.
Empowering a Global Creator Community
Key Upgrades in Meshy 5 Include:
From Meshy 4 to Meshy 5: Reinforcing the Foundation
Meshy 5 enhances the geometry, texture pipeline, and reliability established by Meshy 4, reducing manual work and accelerating asset development. The platform integrates seamlessly with different tools, making it suitable for concept design, rigged production assets, and animation workflows.
Industry Engagement
Meshy will showcase Meshy 5 at Gamescom 2025 in Cologne, following its participation in leading events such as PGC, ChinaJoy, CGDC, and GDC, further highlighting its growing role in next-generation 3D content creation.
What Sets Meshy Apart
Frequently Asked Questions
About Meshy.ai
Meshy.ai is a global leader in AI-powered 3D content generation, trusted by millions of creators. The platform provides advanced tools that accelerate 3D workflows while giving artists full creative control.
Media Contact Information
Meshy.ai
marketing@meshy.ai
https://www.meshy.ai/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263875
BROOKLYN, N.Y., June 8, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Forest Young…
IIG's constructed, owned-and-operated northern corridor is attracting strong customer demand, with further expansion already under…
As of the 2025 filing season, the IRS is applying First-Time Abatement automatically - without…
WASHINGTON, DC / ACCESS Newswire / June 8, 2026 / AGS Health®, a leading provider…
Proof-of-concept SHEPHERD study will assess SUL-238's effects on mitochondrial function in patients with Parkinson's disease.…
FAIRFIELD, NJ / ACCESS Newswire / June 8, 2026 / Jerash Holdings (US), Inc. (Nasdaq:JRSH),…